← Open Payments lookup

EVA CATALAN: Open Payments

NPI 1174125272 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,600 in 155 payments from 39 companies in 2025. Trend: 2023 $399 · 2024 $4,482 · 2025 $4,600

Food & beverage: $3,423Long term medical supply or device loan: $1,098Education: $79
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation23$1,357
AstraZeneca Pharmaceuticals LP12$297
Janssen Biotech, Inc.8$250
Tempus AI, Inc6$193
ABBVIE INC.7$187
PFIZER INC.8$165
Daiichi Sankyo Inc.6$150
Takeda Pharmaceuticals U.S.A., Inc.5$148
Gilead Sciences, Inc.7$139
Merck Sharp & Dohme LLC7$136

Products named: KISQALI, ENHERTU, XT CDX, Trodelvy, IMFINZI, RYBREVANT, EPKINLY, KEYTRUDA.

Industry payments across TX — which companies pay providers there.